Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
Treat COVID-19 Patients With Regadenoson

More than 17 million people have been infected and more than 677K lives have been lost since the COVID-19 pandemic. Unfortunately, there is neither an effective treatment nor is there a vaccination for this deadly virus. The moderate to severe COVID-19 patients suffer acute lung injury and need oxygen therapy, …

respiratory failure
pao2
vaccination
covid-19
respiratory disease
  • 0 views
  • 24 Mar, 2022
  • 1 location
Angiotensin 1-7 as a Therapy in the Treatment of COVID-19

Phase 2 ,double blind, randomized study of therapy with Angiotensin 1-7 in COVID-19 patients. 120 confirmed SARS-CoV-2 infected patients who exhibit moderate- clinical symptoms including dyspnea, cough and fever, hospitalized in the KETER department in several hospitals in Israel, will be enrolled. 60 patients will receive Ang 1-7 subcutaneously 500 …

  • 0 views
  • 30 Jan, 2021
  • 1 location
AV-001 for Hospitalized Patients With COVID-19 Disease

A Phase 2a, randomized, double-blind, placebo-controlled, dose-escalation study in patients hospitalized with confirmed severe coronavirus disease 2019 (COVID-19). The purpose of this study is to examine the safety, tolerability and efficacy of AV-001 Injection administration daily to the earlier of day 28 or EOT (day prior to hospital discharge) to …

pao2
coronavirus
FIO2
oximetry
pneumonia
  • 0 views
  • 13 Jun, 2022
  • 1 location
Cyclosporine For The Treatment Of COVID-19(+)

Phase IIa clinical trial in which 75 non-ICU hospital inpatients will be randomized 2:1 to 7 days of an oral formulation of cyclosporine, Neoral (2.5mg/kg PO BID) + standard of care (SOC) or no Neoral + SOC. The primary endpoint is disease severity based on the World Health Organization (WHO) …

Accepts healthy volunteers
  • 15 views
  • 03 Nov, 2021
  • 1 location
Real World Study of COVID-19 in a Flyover Region

Real world data are needed on remdesivir (RDV) efficacy in COVID-19, especially in the underserved populations of the United States (U.S.) Gulf Coast as initial clinical trials may not be

  • 0 views
  • 28 Oct, 2021
  • 1 location
The UCSD Human Milk Biorepository

The purpose of the UCSD Human Milk Biorepository is to establish and maintain a repository of breast milk samples that can be used to learn more about how breast milk influences infant and child health.

Accepts healthy volunteers
  • 0 views
  • 17 Oct, 2022
  • 1 location
Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 (CovidTox)

used molecules, including but not limited to protease inhibitors (lopinavir/ritonavir), chloroquine, azithromycin, remdesivir and interferon beta-1a. Analyses of reports also include the International

lopinavir/ritonavir
remdesivir
coronavirus
lopinavir
azithromycin
  • 10 views
  • 02 Mar, 2022
  • 1 location
Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19)

The objective of the study is to estimate the frequency of cardiac arrhythmias and characterize the mode of death in patients with coronavirus disease (SARS-CoV-2; COVID-19). The study will also evaluate the long term cardiac outcomes in patients previously diagnosed with COVID-19. This is a single-center, retrospective/ prospective registry enrolling …

  • 50 views
  • 26 Apr, 2022
  • 1 location
Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study

between specific treatments, including but not limited to vaccines targeted against SARS-CoV-2, hydroxychloroquine, azithromycin, remdesivir, baricitinib, tocilizumab, sarilumab, lopinavir/ritonavir and

mechanical ventilation
tocilizumab
lopinavir/ritonavir
azithromycin
covid-19
  • 67 views
  • 05 Mar, 2022
  • 2 locations